Aptose Biosciences Inc. (NASDAQ:APTO) Given Consensus Recommendation of Buy by Analysts

Shares of Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) have been assigned a consensus recommendation of “Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have updated their coverage on […]

Related Keywords

Texas ,United States ,Canada ,Aptose Biosciences ,Piper Sandler ,Texas Capital Bank Wealth Management Services Inc ,Aptose Biosciences Inc ,Nasdaq ,Aptose Biosciences Company Profile ,Sigma Planning Corp ,Annandale Capital ,Get Free Report ,Marketbeat Ratings ,Planning Corp ,Get Free ,Biosciences Inc ,Aptose Biosciences Daily ,Nasdaq Apto ,Dapto ,Medical ,Ratings ,Consensus ,